{"id":31207,"title":"Immunogenicity and safety of a booster dose of an investigational adjuvanted polyprotein HIV-1 vaccine in healthy adults and effect of administration of chloroquine.","abstract":"","date":"2014-02-27","categories":"Chemically-Induced Disorders","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24391139","annotations":[{"name":"HIV","weight":0.277122,"wikipedia_article":"http://en.wikipedia.org/wiki/HIV"},{"name":"Vaccine","weight":0.196383,"wikipedia_article":"http://en.wikipedia.org/wiki/Vaccine"},{"name":"Protein","weight":0.153777,"wikipedia_article":"http://en.wikipedia.org/wiki/Protein"},{"name":"Immunogenicity","weight":0.0628012,"wikipedia_article":"http://en.wikipedia.org/wiki/Immunogenicity"},{"name":"Dose (biochemistry)","weight":0.0391252,"wikipedia_article":"http://en.wikipedia.org/wiki/Dose_(biochemistry)"},{"name":"Medical research","weight":0.0370044,"wikipedia_article":"http://en.wikipedia.org/wiki/Medical_research"},{"name":"Chloroquine","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Chloroquine"},{"name":"Booster dose","weight":0.0279372,"wikipedia_article":"http://en.wikipedia.org/wiki/Booster_dose"},{"name":"Safety","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Safety"},{"name":"Administration of business","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Administration_of_business"}]}
